Use of midostaurin for treating gastrointestinal stromal tumors

Details for Australian Patent Application No. 2005279344 (hide)

Owner Novartis AG

Inventors Cools, Jan

Agent Davies Collison Cave

Pub. Number AU-B-2005279344

PCT Pub. Number WO2006/024494

Priority 60/605,771 31.08.04 US

Filing date 30 August 2005

Wipo publication date 9 March 2006

Acceptance publication date 12 November 2009

International Classifications

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

15 March 2007 PCT application entered the National Phase

  PCT publication WO2006/024494 Priority application(s): WO2006/024494

12 November 2009 Application Accepted

  Published as AU-B-2005279344

11 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005279346-A pressureless polymer pipe, a composition therefore, and a process for preparing it

2005279337-Amide derivatives of 7-amino-3-phenyl-dihydropyrimido [4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents